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Abstract: [D-Ala2, D-Leu5] enkephalin (DADLE), a delta opioid receptor agonist, can induce mammalian hibernation
and has hibernation-like effects in non-hibernating species. It has also been demonstrated that DADLE has protective
efficacy on various tissues such as nervous, cardiac, and hepatic tissues. Despite substantial research conducted in the last
decade about the tissue protective efficacy of DADLE, detailed underlying mechanisms have not been fully elucidated. In
the present study we investigated in a rat model whether continuous perfusion of DADLE can induce potentially tissue
protective alterations in physiological parameters. In the study 48 young male Wistar rats were used. They were divided
into control and experimental groups, each group consisting of 24 animals. DADLE was perfused to experimental group
rats continuously for 28 days using subcutaneously implanted osmotic mini-pumps. We investigated its effects on body
temperature, antioxidant protection [total antioxidant capacity (TAC), ascorbic acid (AA), and malondialdehyde (MDA)
levels], white blood cell (WBC) count, and coagulation parameters [activated partial thromboplastin time (APTT),
prothrombin time (PT), thrombin time (TT)]. While thrombin time was significantly lengthened in the DADLE treated
group, there were no statistically significant differences in the other investigated parameters between the experimental
group and the control group.
Key words: DADLE, opioid, hibernation, osmotic mini-pumps, rats

Hibernasyonu tetikleyici opioid DADLE’nin kronik sürekli perfüzyonu sıçanda
majör bir fizyolojik değişikliğe neden olmadı
Özet: [D-Ala2, D-Leu5] enkephalin (DADLE), memeli hibernasyonunu başlatabilen ve hibernant olmayan türlerde
de hibernasyon benzeri etkilere neden olabilen bir delta opioid reseptör agonistidir. Ayrıca DADLE’nin sinir, kalp
ve karaciğer dokusu gibi çeşitli dokular üzerinde koruyucu etkinliğinin olduğu gösterilmiştir. DADLE’nin doku
koruyucu etkinliği üzerine son yıllarda yürütülen çok sayıda araştırmaya rağmen, bu etkinliğin altında yatan detaylı
mekanizma tam anlamıyla aydınlatılamamıştır. Biz bu çalışmada DADLE’nin sürekli perfüzyonunun sıçanda fizyolojik
parametrelerde potansiyel olarak doku koruyucu etkiler oluşturup oluşturamayacağını araştırdık. Çalışmada 48 adet
erkek Wistar sıçan kontrol ve deney grubu olarak 24’erli iki gruba ayrıldı. DADLE, deney grubu hayvanlarına deri altına
implante edilmiş ozmotik mini pompalar ile 28 gün boyunca sürekli perfüze edildi. DADLE’nin vücut ısısı, antioksidan
savunma sistemi (total antioksidan kapasitesi (TAC), askorbik asit (AA), malondialdehit (MDA) düzeyleri), lökosit
sayısı (WBC) ve koagulasyon parametreleri [active parsiyel tomboplastin zamanı (APTT), protrombin zamanı (PT),
trombin zamanı (TT)] üzerine etkisi incelendi. Deneme grubunda trombin süresi anlamlı olarak uzarken, incelenen
diğer parametreler açısından her iki grup arasında istatistiksel düzeyde anlamlı fark bulunmadı.
Anahtar sözcükler: DADLE, opioid, hibernasyon, ozmotik mini-pompa, sıçan
* E-mail: iakyazi@istanbul.edu.tr
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Introduction
Hibernation is a physiological phenomenon that
consists of various physiological alterations such as
hypothermia, long-term aphagia, bradycardia, and
metabolic depression, which certain animal species
experience when they are exposed to the extremes
of cold and limited food supplies (1,2). Hibernation
represents a unique physiological adaptation that
allows animals to survive in challenging natural
conditions such as extended periods of food
deprivation and extreme cold weather (3).
Physiological parameters of animals show extreme
variations during the hibernation period; colonic
temperatures fall to as low as –1.3 °C (4), basal
metabolic rate decreases to 1%, oxygen consumption
decreases to 50%, respiration rate decreases to 1-2
respiration per minute, and heart rate decreases
to 3-10 beats per minute (5). Non-hibernating
species cannot tolerate these extreme variations in
physiological parameters. Hibernation is a natural
adaptation mechanism useful in conditions that
can cause neural loss and brain damage in nonhibernating animals within minutes, especially
considering significantly reduced blood circulation
and oxygen level in brain tissue (3,6).
There is a “triggering substance” or hibernation
induction trigger (HIT) in the blood of hibernating
mammals, which is responsible for natural
hibernation and can induce hibernation in euthermic
individuals of the same species via blood transfusion
(7). It was found that HIT is not species specific (8)
and has a wide range of physiological effects on nonhibernating species (1,9). Oeltgen et al. (2) found
that DADLE, which is a delta opioid receptor agonist,
induces hibernation in summer-active ground
squirrels in a manner comparable to that induced
by HIT. Similar to HIT, direct infusion of DADLE
leads to hibernation-like effects such as respiratory
depression, analgesia, hypotension, and decreased
heart rate in non-hibernators (9).
Both HIT and DADLE have been reported
to prolong tissue survival time of various organs
such as the heart, lung, liver, and kidney (10,11).
Yamanouchi et al. (12) reported that DADLE protects
the liver against ischemia/reperfusion (IR) injury
in rats. Moreover, it has been shown that DADLE
has neuroprotective efficacy in the central nervous
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system, and it has been suggested that DADLE
might be of important clinical value in the therapies
of neurodegenerative diseases (13-15). Despite
substantial research conducted in the last decade
about the tissue protective efficacy of DADLE,
detailed underlying mechanisms have not been fully
elucidated.
Previous research investigated DADLE’s general
tissue protective effects in vivo and in vitro with both
acute and chronic applications (12-16). Most of the
research mentioned above focused on the protective
efficacy of DADLE against potentially damaging
harmful impacts from various sources such as
toxic agents, asphyxia, ischemia, and hemorrhagic
shock. On the other hand, the effects of DADLE on
various physiological parameters without exposure
to any harmful impact are worth investigating to
elucidate the underlying mechanisms of DADLE’s
protective efficacy. To the best of our knowledge,
no study has investigated the effects of continuous
DADLE infusion on physiological parameters of a
non-hibernating species to date. In this context, in
the present study we aimed to investigate the effects
of long-term continuous infusion of DADLE (rate
of 2.5 μL/h, 0.5% DADLE solution) in rats. Tissue
protective efficacy of DADLE has been mainly
attributed to decreasing lipid peroxidation and to
preventing free radical formation (13,16). Therefore,
the core of investigated parameters in this study has
consisted of the parameters related to the antioxidant
defense system: malondialdehyde (MDA) levels as
an indicator of lipid peroxidation, total antioxidant
capacity (TAC), and plasma ascorbic acid level (AA).
Additionally, since DADLE leads to hibernationlike effects in non-hibernators (9), physiological
and hematological parameters related to the
potentially neuroprotective aspects of hibernation
were also monitored. These are hypothermia (body
temperature), immunomodulation (WBC count),
and hypocoagulation (APTT, PT, TT).
Materials and methods
Forty-eight young male Wistar rats (mean body
weights: 250.09 ± 24.59 g) were used in the study.
They were housed individually with water and
commercial rat pellets available ad libitum and were
maintained on a 12/12 h light/dark cycle. The rats were
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divided into 2 groups as control and experimental
groups, and each group consisted of 24 animals.
Body temperatures of animals were measured and
recorded daily during the experimental period. All
experimental procedures were approved by İstanbul
University Veterinary Faculty’s Ethics Committee.

Brain tissues of animals were removed, washed in
ice-cold buffer (140 mM KCl, 20 mM Tris- HCl, pH
7.4) and homogenized with the same buffer solution.
Homogenates were centrifuged (20,000 ×g / 4 °C /10
min), and TAC, total protein (TP), and MDA levels
were measured in supernatants.

Mini osmotic pumps (2ML4, Alzet-Durect,
Cupertino, USA) containing 0.5% DADLE
solution and physiologic saline were implanted
subcutaneously into the interscapular region of
experimental and control animals, respectively,
under xylazine/ketamine (10/75 mg/kg) anesthesia at
the first day of the experimental study. Experimental
group animals received 2.5 μL, 0.5% DADLE solution
subcutaneously per hour (the mean pumping rate
of osmotic pumps) during the 28-day experimental
period.

MDA level was measured by monitoring
thiobarbituric acid reactive substance formation
according to the method described by Yoshioka et
al. (17). TAC levels of brain tissue and plasma were
measured by an automated analyzer (Aeroset, Abbott,
USA) using kits developed by Erel (18).

At the end of the experimental period, blood
samples were collected via cardiac puncture under
xylazine/ketamine (10/75 mg/kg) anesthesia, and
the animals were sacrificed. Coagulation screening
tests (APTT, PT, and TT) and leukocyte counts were
performed in citrated and heparinized blood samples,
respectively. APTT, PT, and TT were measured using
commercial kits (Diagnostica Stago, France) by
magnetic coagulometer (Amelung, KC1, Germany).
Leukocyte counts were determined by an automated
cell counter (Medonic 570, Sweden).

The plasma level of ascorbic acid was detected
spectrophotometrically using the method of Haag
(20).

The remaining amount of heparinized blood was
centrifuged, and plasma was separated to be used for
determination of TAC, AA, and MDA levels.

The daily mean body temperatures of the groups
are presented in Figure 1. There was no significant
difference between the groups.

Total protein concentration of brain tissue was
estimated by using the method of Lowry et al. (19).
TAC and MDA levels of brain tissue are expressed
as nmol/mg and mmol trolox equiv./mg of tissue
protein, respectively.

All statistical analyses were performed with
SPSS (version 10.0) using the independent samples
t-test. Results are reported as means ± SEM for the
comparison between study and control group values.
Significance was accepted at P < 0.05 level.
Results
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Figure 1. The daily mean body temperatures of the DADLE treatment and control
groups. (Standard errors of the daily mean values are expressed as error bars.)
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The coagulation parameters (APTT, PT,
TT) are shown in Table 1. The activated partial
thromboplastin time and prothrombin time were not
altered by DADLE treatment. The thrombin time of
the DADLE treated group was significantly longer
than that of the control group.
Although there was a small tendency for a
decrease in WBC count of the DADLE treated
group compared to control animals (Figure 2), this
numerical decrease was not statistically significant.
DADLE did not cause any statistically significant
change in AA level in plasma (Figure 3) or TAC in
plasma and brain (Table 2). Consistently the MDA
levels in both groups were not significantly different
(Table 3).

mice when they applied DADLE intraperitoneally (IP).
Briefly, the hypothermic effect of DADLE, observed
dose-dependently after the administrations into the
central nervous system, cannot be seen in systemic
applications. It has been suggested that the permeation
of DADLE across the blood brain barrier (BBB) is low
due to its unfavorable physiochemical properties (22).
The limited BBB permeability of DADLE can explain
the ineffectiveness of systemic administration on body
temperature in the present study.
To the best of our knowledge, there is no
previous study investigating the effects of DADLE
on coagulation related parameters. In this study
while TT level increased (P < 0.05) in the DADLE
treated group, there was no statistically significant
difference between the groups in terms of APTT

Discussion
7
6.8
6.6
10.000/mm3

To the best of our knowledge, the present study
is the first investigating the effects of long-term
continuous infusion of DADLE in a non-hibernating
species. In this study, 28 days of continuous,
subcutaneous perfusion of 0.5% DADLE solution
at a rate of 2.5 μL/h did not cause any statistically
significant change in body temperature (Figure
1). Vybíral and Janský (21) found short-lasting
hypothermia when DADLE was injected directly into
the hypothalamus of rats. They did not observe any
effects when applying it at a lower dose in the same
way or at a 10-fold dose intravenously. Tsao et al. (13)
failed to detect any change in body temperature of

6.4
6.2
6
5.8
5.4
5.2
5

Figure 2. White blood cell (WBC) counts of the DADLE
treatment and control groups. (Values are expressed as
means and standard errors of the mean are shown as
error bars. n = 24 per group.)

24
23

10.00 ± 1.3

10.23 ± 0.7

PT (s)

14.76 ± 0.5

15.27 ± 1.3

μmol/L

DADLE

APTT (s)

DADLE

5.6

Table 1. Coagulation parameters. (n = 24 per group) APTT,
activated partial thromboplastin time; PT, prothrombin
time; TT, thrombin time.

Control

Control

Control

22
DADLE
21
20
19

TT (s)

22.71 ± 1.7

47.90 ± 4.0*

Values are expressed in seconds, as means ± standard error of
the mean.
* Difference between groups is statistically significant (P < 0.05)
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Figure 3. Plasma ascorbic acid (AA) levels of the DADLE
treatment and control groups. (Values are expressed as
means and standard errors of the mean are shown as
error bars. n = 24 per group.)

İ. AKYAZI, Ü. ÇÖTELİOĞLU

Table 2. Total antioxidant capacity in plasma and brain
(n = 24 per group).

Control

DADLE

Plasma
(mmol trolox equiv./L )

0.763 ± 0.02

0.745 ± 0.01

Brain
(mmol trolox equiv./ mg
protein)

11.992 ± 0.18

11.810 ± 0.10

Table 3. Malondialdehyde (MDA) levels in plasma and brain
(n = 24 per group).

Control

DADLE

Plasma
(nmol/mL)

10.415 ± 0.32

10.967 ± 0.22

Brain
(nmol/mg protein)

0.7999 ± 0.04

0.8262 ± 0.05

Values are expressed as means ± standard error of the mean.
Values are expressed as means ± standard error of the mean.

or PT (Table 1). Hypocoagulation, which is an
important component of neuroprotective adaptation
seen in hibernation, is attributed to increased levels
of α-2 macroglobulin (α-2M) (23). α-2M binds
factor Xa in the coagulation cascade and inhibits
this activated factor at the intersection point of the
intrinsic and extrinsic coagulation pathways and it
also binds thrombin (24). In this study, increased
TT, which assesses the activity of these 2 important
components of the coagulation cascade, may be
explained by the possibility of increased α-2M level
in the experimental group animals.
Although there are some studies examining
the immunomodulating effects of DADLE and
other opioid agonists (25), the effects of systemic
DADLE application on the leukogram has not been
investigated thoroughly. In this study it was found
that the leukocyte count of experimental group
animals had a tendency to decrease compared to
that of the control group, but this is not statistically
significant (Figure 2). Rahim et al. (26) found that
applying delta opioid agonists using osmotic pumps
has an immune suppressive effect. Although the
tendency for a decrease in WBCs in the experimental
group was not statistically significant, this numerical
decrease may be the result of increased leukocyte
margination similar to the one seen in hibernation
(6).
A few studies investigated the effects of DADLE
on antioxidant status and oxidative stress. In one of
these, Tsao et al. (13) found that intraperitoneally
applied DADLE was neuroprotective in the central
nervous system and attributed this protective effect

of DADLE to both activation of delta opioid receptors
and its free radical scavenging property in vitro. It has
been demonstrated that intravenously administered
DADLE protects the liver against IR injury by
reduction of lipid peroxidation (12). More recently,
Yang et al. (16) reported that systemically applied
DADLE attenuates oxidative injury in the brain by
enhancing antioxidant ability via DOR activation. In
the present study, subcutaneous infusion of DADLE
did not cause any significant alteration in parameters
related to the antioxidant defense system (AA, TAC,
MDA). This ineffectiveness could have been due to
the low dose administered in our study, and the free
radical scavenging property of DADLE might not
have been sufficient to reveal any antioxidant activity
in this low dose. Moreover, Tao et al. (27) reported
that chronic DADLE treatment caused a decrease
in DOR density in the rat brain. In this context, it
seems possible that the chronic continuous infusion
of DADLE in the present study might have similarly
decreased the delta-opioid receptor density, and,
therefore, DADLE treatment might not have caused
any significant effect.
In conclusion, although DADLE was found
to be a neuroprotective agent and had significant
tissue protective effects in several studies and
multiorgan preservation experiments, in this study
subcutaneous infusion of 0.5% DADLE solution
at the rate of 2.5 μL/h continuously for 28 days did
not have any positive effects in rats concerning the
antioxidant defense system and some additionally
parameters related to the neuroprotective adaptation
of hibernation.
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